Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer patients

Study shows valuable role of Mammostrat in assessing ER+ postmenopausal breast cancer patients

Variation in microRNAs may explain survival differences in breast cancer

Variation in microRNAs may explain survival differences in breast cancer

Favorable results from CytRx’s INNO-206 Phase 1b/2 trial on soft tissue sarcomas

Favorable results from CytRx’s INNO-206 Phase 1b/2 trial on soft tissue sarcomas

America's biopharmaceutical researchers work on many new approaches to fight cancer

America's biopharmaceutical researchers work on many new approaches to fight cancer

Distinctive protein pathways in certain leukemia patients

Distinctive protein pathways in certain leukemia patients

LILRB2 receptor plays an important role in keeping stem cells from differentiating

LILRB2 receptor plays an important role in keeping stem cells from differentiating

Study examines how SMIP-016 drug kills CLL cells

Study examines how SMIP-016 drug kills CLL cells

TAU researcher develops new antibodies to target and destroy cancer cells

TAU researcher develops new antibodies to target and destroy cancer cells

Experimental drug shows promise for elderly chronic leukemia patients

Experimental drug shows promise for elderly chronic leukemia patients

Beyond chemotherapy to cure leukemia

Beyond chemotherapy to cure leukemia

CytRx INNO-206 doxorubicin conjugate shows anti-multiple myeloma effects

CytRx INNO-206 doxorubicin conjugate shows anti-multiple myeloma effects

JTCC to present latest findings in blood-cancer research at ASCO annual meeting

JTCC to present latest findings in blood-cancer research at ASCO annual meeting

Scientists show why leukemia often returns

Scientists show why leukemia often returns

Naphthalene exposure may increase risk of chromosomal aberrations in children

Naphthalene exposure may increase risk of chromosomal aberrations in children

Scientists develop synthetic peptide that overcomes cancer cells’ survival defenses

Scientists develop synthetic peptide that overcomes cancer cells’ survival defenses

City of Hope receives CIRM grant to develop T cell-based immunotherapy against glioma

City of Hope receives CIRM grant to develop T cell-based immunotherapy against glioma

Overactive BAALC gene found in people with acute leukemia

Overactive BAALC gene found in people with acute leukemia

FDA reauthorization bill sails through Senate

FDA reauthorization bill sails through Senate

Thioridazine drug successfully kills human cancer stem cells

Thioridazine drug successfully kills human cancer stem cells

New compound can enhance apoptosis in cancer cells

New compound can enhance apoptosis in cancer cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.